Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03116737 · ClinicalTrials.gov registry record · Phase 3
Phase III Study Evaluating Topical Benzocaine for Treatment of Acute Otitis Media in Children
A Phase 3 study of Pain and Acute Otitis Media, sponsored by Lachlan Pharma Holdings.
- Completed
- Registry status
- Phase 3
- Development phase
- 141
- Enrollment target
- 1
- Study location
NCT03116737: Completed Phase 3 study of Pain and Acute Otitis Media, sponsored by Lachlan Pharma Holdings.
NCT03116737 is a Phase 3 study of Pain and Acute Otitis Media that has completed, run by Lachlan Pharma Holdings. The registered enrollment target is 141 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (54% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03116737, a Phase 3 study of Pain and Acute Otitis Media, has completed, sponsored by Lachlan Pharma Holdings.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 141 participants
- Enrollment target
- 1
- Study location
Study Summary
The Phase III study is designed to assess the safety, tolerability, and efficacy of Topical Benzocaine in children, ages 5 to 12 years, presenting with Acute Otitis Media-associated ear pain.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Benzocaine Otic Solution
Study Locations (1)
Oregon
- Cyn3rgy Research - Gresham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 141 participants |
| Start Date | 2017-01-03 |
| Est. Completion | 2017-07-21 |
| Phase | Phase 3 |
What the finished NCT03116737 record still lists
NCT03116737 is an interventional study that assigns participants to a tested intervention. The registered 141 participants enrollment target is mid-sized for trials with a published cap, below the 304-participant average among 374 other Pain trials with a reported enrollment target (54% lower).
The record links to 2 conditions, with Pain appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT03116737 reports a single indexed study location in Oregon.
Frequently Asked Questions
What is clinical trial NCT03116737 about?
NCT03116737 is a clinical study titled "Phase III Study Evaluating Topical Benzocaine for Treatment of Acute Otitis Media in Children". The Phase III study is designed to assess the safety, tolerability, and efficacy of Topical Benzocaine in children, ages 5 to 12 years, presenting with Acute Otitis Media-associated ear pain.
What is the current status of trial NCT03116737?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 141 participants. The study started on 2017-01-03. Estimated completion is 2017-07-21.
What conditions does trial NCT03116737 study?
This clinical trial studies the following conditions: Pain, Acute Otitis Media.
What interventions are being tested in trial NCT03116737?
The interventions under investigation include: Placebo (DRUG), Benzocaine Otic Solution (DRUG).
Who is sponsoring clinical trial NCT03116737?
This trial is sponsored by Lachlan Pharma Holdings, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03116737 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03116737's enrollment target sits among peer trials
141 122nd of 374 higher than 253 of 374 other Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effect of NSAIDs on Union, Opioid Utilization and Pain Management for Tibia Fractures: A Pragmatic, Randomized Controlled Trial
RECRUITING · Phase 3
-
Opioid-Free Orthopaedics
RECRUITING · Phase 3
-
Suzetrigine in Total Hip Arthroplasty
RECRUITING · Phase 3
-
Optimizing Chronic Pain Care With Mindfulness and Chronic Pain Management Visits
RECRUITING · Phase 3
-
Implementation and Effectiveness of Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone Treatment
RECRUITING · Phase 3
-
Post-Op Pain Control for Prophylactic Intramedullary Nailing.
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03042962 · 141 participants
Brain Networks in Dystonia
- NCT04378439 · 141 participants · NA
Appalachian Partnership to Reduce Disparities (Aim 2)
- NCT04775485 · 141 participants · Phase 2
A Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With Relapsed or Progressive Low-Grade Glioma and Advance Solid Tumors
- NCT05040360 · 141 participants · Phase 2
Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI